Eli Lilly and Co
NYSE:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
NYSE:LLY
Watchlist
Price: 795.12 USD 0.36% Market Closed
Market Cap: 753.6B USD

Intrinsic Value

The intrinsic value of one LLY stock under the Base Case scenario is 357.39 USD. Compared to the current market price of 795.12 USD, Eli Lilly and Co is Overvalued by 55%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LLY Intrinsic Value
357.39 USD
Overvaluation 55%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Eli Lilly and Co

Valuation History Unavailable

Historical valuation for LLY cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare LLY to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Despite the significant buzz around tirzepatide and other diabetes products, their high development and marketing costs could erode profitability if insurance reimbursement or pricing pressures intensify, particularly in today’s cost-conscious healthcare environment.

Bull Theses

Tirzepatide’s rapid approvals and robust clinical outcomes in diabetes and obesity treatments position Eli Lilly to capture valuable market share in a high-growth therapeutic area, protecting long-term revenue streams.

Show More Less
How do you feel about LLY?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Eli Lilly and Co
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Eli Lilly and Co

Current Assets 41.3B
Cash & Short-Term Investments 3.2B
Receivables 14B
Other Current Assets 24B
Non-Current Assets 48.1B
Long-Term Investments 3.2B
PP&E 18.5B
Intangibles 11.8B
Other Non-Current Assets 14.6B
Efficiency

Free Cash Flow Analysis
Eli Lilly and Co

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Eli Lilly and Co

Revenue
49B USD
Cost of Revenue
-9B USD
Gross Profit
40B USD
Operating Expenses
-20.3B USD
Operating Income
19.7B USD
Other Expenses
-8.6B USD
Net Income
11.1B USD
Fundamental Scores

LLY Profitability Score
Profitability Due Diligence

Eli Lilly and Co's profitability score is 75/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional ROE
Positive Operating Income
75/100
Profitability
Score

Eli Lilly and Co's profitability score is 75/100. The higher the profitability score, the more profitable the company is.

LLY Solvency Score
Solvency Due Diligence

Eli Lilly and Co's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
64/100
Solvency
Score

Eli Lilly and Co's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LLY Price Targets Summary
Eli Lilly and Co

Wall Street analysts forecast LLY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LLY is 987.06 USD with a low forecast of 681.75 USD and a high forecast of 1 249.5 USD.

Lowest
Price Target
681.75 USD
14% Downside
Average
Price Target
987.06 USD
24% Upside
Highest
Price Target
1 249.5 USD
57% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for LLY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

LLY Insider Trading
Buy and sell transactions by insiders

LLY News

Other Videos
What is the Intrinsic Value of one LLY stock?

The intrinsic value of one LLY stock under the Base Case scenario is 357.39 USD.

Is LLY stock undervalued or overvalued?

Compared to the current market price of 795.12 USD, Eli Lilly and Co is Overvalued by 55%.

Back to Top